The pharmaceutical industry is continuously evolving, with growing demand for high-performance Active Pharmaceutical Ingredients (APIs). Dulaglutide, a GLP-1 receptor agonist, is a key example of this trend. To address this demand, US-based manufacturing services are emerging. These providers offer a comprehensive suite of services, from research a